Drug name - Qudexy Xr
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10363224 | UPSHER SMITH LABS | Extended-release topiramate capsules |
Mar, 2033
(10 years from now) | |
| US8889190 | UPSHER SMITH LABS | Extended-release topiramate capsules |
Mar, 2033
(10 years from now) | |
| US9101545 | UPSHER SMITH LABS | Extended-release topiramate capsules |
Mar, 2033
(10 years from now) | |
| US9555005 | UPSHER SMITH LABS | Extended-release topiramate capsules |
Mar, 2033
(10 years from now) | |
| US8652527 | UPSHER SMITH LABS | Extended-release topiramate capsules |
Mar, 2033
(10 years from now) | |
Drugs and Companies using TOPIRAMATE ingredient
Treatment: Treatment of seizures
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 25MG | CAPSULE, EXTENDED RELEASE;ORAL | Prescription |
| 50MG | CAPSULE, EXTENDED RELEASE;ORAL | Prescription |
| 100MG | CAPSULE, EXTENDED RELEASE;ORAL | Prescription |
| 150MG | CAPSULE, EXTENDED RELEASE;ORAL | Prescription |
| 200MG | CAPSULE, EXTENDED RELEASE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.